Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is epithelial-myoepithelial carcinoma (salivary gland)?
Epithelial-myoepithelial carcinoma is an uncommon salivary-gland cancer named for the two kinds of cells it contains: inner duct-lining (epithelial) cells and outer 'myoepithelial' cells that normally help squeeze saliva out of the glands. It most often arises in the parotid gland (in front of the ear) and usually appears as a slowly growing, painless lump. Most of these tumors are low-grade and have a good outlook, but they are known for a tendency to come back in the same area if not fully removed, and a minority can transform into a higher-grade, more aggressive cancer. Because it is rare and can resemble other salivary tumors under the microscope, an experienced pathologist is important for diagnosis. Treatment centers on complete surgical removal, with radiation added when there are features that raise the risk of recurrence.
The main types
Doctors group epithelial-myoepithelial carcinoma (salivary gland) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Conventional (low-grade) epithelial-myoepithelial carcinoma | The usual form — a slow-growing tumor with a generally good outlook, treated primarily with surgery. Its main challenge is a tendency to recur locally if not completely removed. |
| High-grade / dedifferentiated epithelial-myoepithelial carcinoma | An uncommon, more aggressive version where part of the tumor has transformed to a higher grade, carrying a greater risk of node and distant spread and needing more intensive treatment. |
Staging, in plain terms
This cancer is staged with the standard TNM system for salivary-gland cancers — the size and reach of the tumor (T), spread to neck lymph nodes (N), and spread to distant organs (M) — together with its grade. Most cases are low-grade and localized, falling into earlier stages with a favorable outlook, though local recurrence is the main concern. Higher-grade or transformed tumors are staged the same way but behave more aggressively.
| Head-and-neck (salivary) TNM + grade | What it generally means |
|---|---|
| Early, low-grade | A small tumor confined to the gland. Treated with complete surgical removal, with an excellent outlook when margins are clear. |
| Larger, recurrent, or node-positive | A bigger tumor, a recurrence, or spread to lymph nodes. Treated with surgery plus radiation to reduce the risk of further local recurrence. |
| High-grade or metastatic | Transformed or distant disease. Treated with surgery and radiation where possible, with systemic therapy or trials considered for widespread disease. |
The standard of care
Epithelial-Myoepithelial Carcinoma (Salivary Gland) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical removal
Taking out the tumor with clear margins — for example, removing part or all of the parotid gland while protecting the facial nerve — is the primary treatment and the best way to prevent recurrence.
Radiation therapy
Radiation is added after surgery for close or positive margins, high-grade or transformed tumors, nerve involvement, recurrence, or lymph-node spread, and can be the main treatment when surgery is not possible.
Neck evaluation
The neck lymph nodes are checked and treated when the tumor is higher-grade or there is concern about spread, which is uncommon in typical low-grade cases.
Long-term follow-up
Because this cancer can recur locally even years later, patients are monitored over time so any recurrence can be found and treated early.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide. For epithelial-myoepithelial carcinoma, surgery is the main treatment, but radiation is an important partner when the risk of the cancer returning is high — for example, when margins are close or positive, the tumor is high-grade or transformed, a nerve is involved, or lymph nodes are affected. It treats the microscopic cells left behind and lowers the chance of local recurrence, which is this tumor's main tendency. Intensity-modulated radiation shapes the dose around the salivary region while sparing healthy glands and swallowing muscles, and proton therapy can further spare nearby tissue for tumors near the skull base or when re-treating a recurrence. Radiation is painless during delivery, given over several weeks of daily sessions, and external-beam treatment leaves no radioactivity in the body.
The main ways radiation is delivered for epithelial-myoepithelial carcinoma (salivary gland):
Intensity-modulated radiation (IMRT)
Beams are shaped around the salivary region to treat the tumor bed while sparing the other salivary glands, swallowing muscles, and jaw to limit dry mouth and other side effects.
Proton therapy (selected)
Protons can reduce dose to nearby structures for tumors near the skull base or when re-treating a recurrence, lowering side effects.
Neutron / particle therapy (selected high-grade)
For aggressive or transformed salivary cancers that resist standard radiation, specialized particle beams at expert centers can improve local control.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Surgery with radiation for high-risk features: Clinical series support complete surgical removal as the cornerstone, with postoperative radiation reducing local recurrence for tumors with positive margins, high grade, or nerve involvement.[1]
Head & Neck and Oral Oncology salivary-tumor outcome studies
High-grade transformation drives outcomes: Studies show that the minority of tumors undergoing high-grade (dedifferentiated) transformation behave much more aggressively, underscoring the value of expert pathology review.[2]
American Journal of Surgical Pathology transformation reports
Molecular features being defined: Research has identified recurrent gene changes (such as HRAS mutations) in many of these tumors, helping confirm the diagnosis and pointing toward possible future targeted approaches.[3]
Modern Pathology molecular characterization studies
Common questions
Is epithelial-myoepithelial carcinoma usually serious? Most are low-grade and slow-growing with a favorable outlook after complete surgery. The main concern is a tendency to recur in the same area, which is why clear surgical margins and, for higher-risk features, radiation matter. A minority transform to a higher grade and need more intensive treatment.
Why might I need radiation if the tumor was removed? Radiation after surgery is recommended when there is a higher chance of microscopic cells being left behind — for example, close or positive margins, a high-grade tumor, nerve involvement, or lymph-node spread. It lowers the risk of the cancer returning in that area.
Will surgery affect my facial movement? Because the facial nerve runs through the parotid gland, surgeons take great care to identify and protect it. Most patients keep normal facial movement; temporary weakness can occur and usually improves. Your surgeon will discuss the risks specific to your tumor.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Head & Neck and Oral Oncology salivary-tumor outcome studies (no indexed identifier — see your care team) ↩
- American Journal of Surgical Pathology transformation reports (no indexed identifier — see your care team) ↩
- Modern Pathology molecular characterization studies (no indexed identifier — see your care team) ↩